World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on January 31, 2026

Jan. 31, 2026

NutriHarvest® Organic Fertilizers Deliver Yield Gains and Stronger Plant Growth in Corn

EIN Presswire

Jan. 31, 2026

High-Grade 1962 Topps Set, Mickey Mantle, and Rare Pre-War Hockey Cards Drive $786,106 in Miller & Miller Sports Auction

EIN Presswire

Jan. 31, 2026

Madhya Pradesh’s Global Tourism Strategy: Insights from Dr. Abhay Arvind Bedekar

EIN Presswire

Jan. 31, 2026

Professional Booth Builder Bangkok Transforms Exhibition Marketing Strategies

EIN Presswire

Jan. 31, 2026

Rahab’s Daughters 11th Annual 'Big Game Mission Trip' to Combat Human Trafficking in the San Francisco Bay Area

EIN Presswire

Jan. 31, 2026

Ohio's Hocking Hills offers last-minute Valentine's Day gifts and romance; Galentine's, group and family getaways

EIN Presswire

Jan. 31, 2026

CO2Lift® Commands the Global Stage at Carboxy Couture Paris

EIN Presswire

Jan. 31, 2026

NOCO Healthcare’s Greeley Primary Care Redefines Community-Focused Medicine

GlobeNewswire

Jan. 31, 2026

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

GlobeNewswire

Jan. 31, 2026

Kyowa Kirin erlangt Kontrolle über Entwicklungs- und Kommerzialisierungsprogramm für Rocatinlimab wieder, zeigt starkes Engagement im Bereich des ungedeckten medizinischen Bedarfs bei atopischer Dermatitis

GlobeNewswire

Jan. 31, 2026

Kyowa Kirin recupera el control del programa de desarrollo y comercialización de rocatinlimab, demostrando un firme compromiso para abordar la elevada necesidad médica no cubierta en la dermatitis atópica

GlobeNewswire

Jan. 31, 2026

協和キリン (Kyowa Kirin)、ロカチンリマブ (Rocatinlimab)…

GlobeNewswire

Jan. 31, 2026

교와기린 (Kyowa Kirin), 로카틴리맙 (Rocatinlimab) 개발·상업화 프로그램 통제권 재확보하며 아토피 피부염 분야의 높은 미충족 의료 수요 해결에 대한 강력한 의지 재확인

GlobeNewswire

Jan. 31, 2026

Kyowa Kirin Recupera Controle do Programa de Desenvolvimento e Comercialização do Rocatinlimab, Demonstrando Forte Compromisso para Abordar a Alta Necessidade Médica Não Atendida na Dermatite Atópica

GlobeNewswire

Jan. 31, 2026

Kyowa Kirin reprend le contrôle du programme de développement et de commercialisation du rocatinlimab, manifestant ainsi son profond engagement visant à répondre aux besoins médicaux non satisfaits dans le domaine de la dermatite atopique

GlobeNewswire

Jan. 31, 2026

Kyowa Kirin תשיב לעצמה שליטה על תוכנית הפיתוח והמסחור של רוקטינלימאב, תוך הפגנת מחויבות חזקה לטיפול בצורך רפואי גבוה שלא הגיב בדלקת עור אטופית

GlobeNewswire

Jan. 31, 2026

Kyowa Kirin akan Mengambil Alih Semula Kawalan ke atas Rocatinlimab Development and Commercialization Program, Sekali Gus Menunjukkan Komitmen Kukuh bagi Menangani Keperluan Perubatan Tinggi yang Belum Dipenuhi dalam Dermatitis Atopik

GlobeNewswire

Jan. 31, 2026

Kyowa Kirin 将重新掌控罗卡替尼单抗的研发及商业化项目，展现其致力于满足特应性皮炎医疗需求巨大缺口的坚定决心

GlobeNewswire

Jan. 31, 2026

Kyowa Kirin 重掌羅卡替尼單抗的研發和商業化項目，展現出致力解決異位性皮膚炎高度未獲滿足醫療需求的堅定承諾

GlobeNewswire

Jan. 31, 2026

Chamelo Debuts Lion City: First Smart Eyewear Crafted from Italian Acetate with Prescription-Ready Design at MIDO 2026

GlobeNewswire